Current Opinion in Infectious Diseases

Article	Citations
Strongyloidiasis-related lung involvement: too much of a bad thing	48
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era	46
Editorial introductions	42
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel	42
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV	40
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians	40
Surgical management of cystic echinococcosis of the liver	37
Skin and soft tissue infections in the elderly	33
Complexities of cardiomyopathy in septic shock	30
From diagnosis to management: current perspectives on congenital cytomegalovirus infection	30
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	29
La Crosse virus encephalitis in children	28
Fusarium species central nervous system infection	28
Corticosteroids for viral central nervous system infections	28
New therapies for nontuberculous mycobacterial lung infection	28
Progress and challenges in human papillomavirus and cervical cancer in southern Africa	26
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response	26
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management	25
Viral meningitis and encephalitis: an update	24
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	24
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?	23
Tuberculosis molecular bacterial load assay in the management of tuberculosis	23
Mycobacterial skin infection	23
Typhoid fever control in the 21st century: where are we now?	23
Mpox in people living with HIV	21

Resistant herpes simplex virus infections – who, when, and what's new?	21
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	21
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?	20
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies	20
Tick-borne encephalitis	19
CMV antiviral stewardship in transplantation – the next frontier	19
Malaria in pregnancy: baby steps	19
Management of neonates born to mothers with active genital herpes simplex virus infection: an alternative approach	18
Does climate change threaten delivery of HIV care in resource-limited settings?	18
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis	18
Diagnostic stewardship: what impacts antibiotics use?	17
Editorial introductions	17
Gut microbiome and its clinical implications: exploring the key players in human health	17
Appropriate surgical management in skin and soft tissue infections	16
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV	16
Diagnostic approach and update on encephalitis	16
Using antibiotics wisely	16
Interventions for polyoma virus-associated hemorrhagic cystitis	16
Risk stratification for selecting empiric antibiotherapy during and after COVID-19	15
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles	15
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change	14
The plumbing problem: rising antimicrobial resistance in building water systems	14
Immunotherapeutic approaches to HIV cure and remission	14
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections	14
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	14
The microbiota in respiratory tract infections: from association to intervention	14
Editorial introductions	13
The impact of coronavirus disease 2019 on people with HIV	13
Update on the treatment of chronic pulmonary aspergillosis	13
Editorial: Pathogenesis and immune response – editorial	12
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae	12
Respiratory syncytial virus prevention in immunocompromised hosts: gaps and opportunities	12
Interpreting and managing preservation fluids positive for Gram-negative bacteria	12
The microbiome as a biomarker of anal precancerous lesions in people with HIV	12
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives	12
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	12
The secret weapon to reduce multidrug-resistant Gram-negative infections: can vaccines help decrease MDR risk?	12
Childhood tuberculosis	12
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential	12
Data science for pediatric infectious disease: utilizing COVID-19 as a model	11
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients	11
Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis	11
Short treatment duration for community-acquired pneumonia	11
Travellers’ diarrhoea – solidifying our knowledgebase	11
An overview of risk factors, management and prevention of cochlear implant infections	11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans	10
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities	10
Update on drug treatments for multidrug resistant tuberculosis	10
Respiratory metagenomics: route to routine service	10
A new era of HIV care for age-associated multimorbidity	10

The disease burden of respiratory syncytial virus in Infants	10
Burden of influenza in the elderly: a narrative review	10
Genome-wide approaches to bacterial strain typing: a history and review of recent methodological advances	9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention	9
The evolution of knowledge for treating Gram-negative bacterial infections	9
Neurobrucellosis	9
Novel techniques in the treatment of skin and soft tissue infection	9
Short-course antibiotic strategies for ventilator-associated pneumonia	9
Therapeutic agents for the treatment of human mpox	9
Updates on the neurological manifestations of SARS-CoV-2 infection	9
The role of Gram-negative bacteria in skin and soft tissue infections	9
Skin and soft tissue infections in solid organ transplants	9
Chagas disease in the immunocompromised host	9
Identifying patients with difficult-to-treat acute bacterial skin infections	9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	9
Immune responses and severe dengue: what have we learned?	9
Urinary tract infections in immunocompromised patients	9
Latent tuberculosis screening and treatment in solid organ and hematopoietic stem cell transplant candidates and recipients	9
Antibiotic treatment of acute bacterial skin and skin structure infections	9
Surgical site infection prophylaxis: what have we learned and are we making progress?	8
The role of older antibiotics in the treatment of skin and soft tissue infections: current perspectives	8
How I manage patients with New Delhi metallo-beta-lactamase and OXA-48-producing Enterobacterales infections: a practical approach	8
Editorial introductions	8
Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice	8
Endemic viral infections in immunocompromised hosts: Dengue, Chikungunya, Zika	8
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	7
When is it a sexually transmitted infection? Intimate contact transmission of pathogens not traditionally defined as STIs	7
Universal versus targeted treatment of neonatal herpes simplex virus among neonates presenting for sepsis evaluations	7
Editorial introductions	7
Long COVID in children and young people: then and now	7
Tropical gastrointestinal infections of contemporary public health importance	7
Editorial introductions	7
Pneumocystis jiroveci: still troublesome to diagnose and treat	7
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach	7
The implications of the COVID-19 pandemic for long term care facilities	7
Management of nonfermenting gram-negative infections: a critique of the guidelines	7
Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections	7
Editorial introductions	6
Antiviral therapies for influenza	6
Community-acquired skin and soft-tissue infections in people who inject drugs	6
Medical management of cystic echinococcosis	6
Editorial: Friends and foes: “The quarrels of friends are the opportunities of foes”	6
Climate change and resilience for antimicrobial stewardship and infection prevention	6
Editorial introductions	6
Choosing antibiotic therapy for severe community-acquired pneumonia	6
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	6
Preventing respiratory viral transmission in healthcare settings	6
Current status of primary, secondary and tertiary prevention of congenital cytomegalovirus disease: a call to action	5
Risk factors for cognitive decline in persons with HIV	5
Biomarkers to predict cardiovascular disease in people living with HIV	5
Horizontal versus vertical strategies for infection prevention: current practices and controversies	5
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	5
Strongyloides stercoralis infection in solid organ transplant recipients	5
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	5
How to use new antibiotics in the therapy of ventilator-associated pneumonia	5
Is it possible to identify genotypes underlying resistant phenotypes in Gram-negative pathogens?	5
Current international and national guidelines for managing skin and soft tissue infections	5
Editorial introductions	5
Dengue encephalitis: what's new?	5
Risk factors for severity in seasonal respiratory viral infections and how they guide management in hematopoietic cell transplant recipients	5
The power of story: what Victorian novels can teach us about public health	5
Editorial introductions	5
From clinical trials to daily practice: how to adequately administer sulbactam-durlobactam? alone or combined with imipenem?	5
Human toxoplasmosis: current advances in the field	5
Viral infections and inborn errors of immunity	5
Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children	4
Respiratory viral infections in children with cancer and febrile neutropenia and children undergoing hematopoietic stem cell transplantation	4
Lenacapavir: a first-in-class capsid inhibitor for HIV treatment and prevention	4
The role of sulbactam-durlobactam in treating carbapenem-resistant Acinetobacter infections	4
Central nervous system infections in the tropics	4
Vaccine hesitancy and other challenges to sexually transmitted infection vaccine acceptance	4
The microbiology and pathogenesis of nonfermenting Gram-negative infections	4
Current challenges in neurocysticercosis: recent data and where we are heading	4
Escherichia coli 0157:H7 virulence factors and the ruminant reservoir	4
Clinical trials that could change the management of severe multidrug-resistant Gram-negative infections	4
The present and future of blood virome in allogeneic hematopoietic cell transplant recipients	4
Nontyphoidal Salmonella infections acquired from poultry	4
Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response	4
Neutropenia and antibiotics: when, what, how and why?	4
To proceed or delay? The dilemma of community-acquired respiratory viruses in adults and pediatrics before allogeneic stem cell transplantation and chimeric-antigen-receptor T-cell therapy	4

Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients	4
Editorial introductions	4
‘No cyst, no echinococcosis’: a scoping review update on the diagnosis of cystic echinococcosis after the issue of the WHO-IWGE Expert Consensus and current perspectives	4
The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections	4
A work in progress: antimicrobial stewardship in solid organ transplant patient populations	4
Editorial introductions	4
Skin and soft tissue infections due to rapidly growing mycobacteria	4
What will it take to meet UNAIDS targets for preexposure prophylaxis users?	4
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients	4
Brain abscess in immunocompetent patients: recent findings	4
Viral diarrheas – newer advances in diagnosis and management	4
Advances and challenges in sexually transmitted infections prevention among men who have sex with men in Asia	4
How to treat severe Acinetobacter baumannii infections	3
Dermatological manifestations during Dengue, Chikungunya, and Zika infections	3
Hot topics in pediatric infectious diseases: vaccines, molecular diagnosis, and emerging challenges post COVID-19	3
Not all carbapenem-resistant Pseudomonas aeruginosa strains are alike: tailoring antibiotic therapy based on resistance mechanisms	3
Host-directed immunotherapy for viral infections	3
Mpox exposure and transmission in healthcare settings during the 2022 global outbreak	3
Endemic mycoses – are we making progress in management?	3
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?	3
Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection – issues and therapeut	3
Current challenges in acute bacterial skin infection management	3
Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus	3
New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria	3
NSAIDs for early management of acute respiratory infections	3
When antimicrobial stewardship begins with microbiological test requests: the case of asymptomatic bacteriuria	3
Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome	3
Hyperammonemia syndrome in immunosuppressed individuals	3
What is the clinical significance of ‘heteroresistance’ in nonfermenting Gram-negative strains?	3
Rectal chlamydia infections: implications for reinfection risk, screening, and treatment guidelines	3
Infant feeding: emerging concepts to prevent HIV transmission	3
Mpox: emergence following smallpox eradication, ongoing outbreaks and strategies for prevention	3